Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Priya Life Science Medicines register
Registers› Irish medicines ›Metoject 20 mg solution for injection in pre-filled pen
Medicines register · Ireland

Metoject 20 mg solution for injection in pre-filled pen

Authorisation PA0623/014/005 · medac Gesellschaft für klinische Spezialpräparate mbH

Source: Health Products Regulatory Authority (HPRA), open dataset, CC BY 4.0. HPRA list dated 22 Nov 2026
Licence holder
medac Gesellschaft für klinische Spezialpräparate mbH (all products →)
Active substance
Methotrexate
Clinical trials
123 clinical trials →
Dosage form
Solution for injection in pre-filled pen
Route of administration
Subcutaneous use
ATC codes
L01BA, L01BA01
First authorised
13/04/2018
Prescription status
Product subject to prescription which may not be renewed (A)
Supply
Supply through pharmacies only
Legal basis
Hybrid application (Article 10(3) of Directive No 2001/83/EC)

Methotrexate: supply and approvals

48 authorised products on the HPRA list contain Methotrexate. Shortage records below are for the substance in the EU, US and German markets and may not affect this Irish product; for Irish supply, check with the HPRA or a pharmacist.

EU shortage (EMA)
Methotrexate: Shortage resolved, first published 9 Aug 2023
US shortage (FDA)
Methotrexate Sodium Injection: in shortage, updated 18 Nov 2026
Germany (BfArM)
14 supply notices, e.g. Methofill 20 mg Injektionslösung im Fertiginjektor (30 Jun 2026 to 31 Dec 2027)

Registers: EU shortages · US shortages · German shortages · EMA approvals

About this licence

National authorisation (PA). A product authorisation granted by the HPRA for the Irish market. It has been authorised for 8 years (since 13 April 2018). The HPRA list marks it as marketed in Ireland.

Other medicines with Methotrexate in Ireland

47 other products on the HPRA list contain Methotrexate, from 10 licence holders; 21 of them are marked as marketed. Products with the same substance can differ in strength, form, other ingredients and what they are licensed for, so they are not automatically interchangeable.

MedicineLicence holderLicenceStatus
Methofill 10 mg solution for injection in pre-filled injectorAccord Healthcare Ireland Ltd.National authorisation (PA)Marketed
Methofill 12.5 mg solution for injection in pre-filled injectorAccord Healthcare Ireland Ltd.National authorisation (PA)Marketed
Methofill 15 mg solution for injection in pre-filled injectorAccord Healthcare Ireland Ltd.National authorisation (PA)Marketed
Methofill 17.5 mg solution for injection in pre-filled injectorAccord Healthcare Ireland Ltd.National authorisation (PA)Marketed
Methofill 20 mg solution for injection in pre-filled injectorAccord Healthcare Ireland Ltd.National authorisation (PA)Marketed
Methofill 22.5 mg solution for injection in pre-filled injectorAccord Healthcare Ireland Ltd.National authorisation (PA)Marketed
Methofill 25 mg solution for injection in pre-filled injectorAccord Healthcare Ireland Ltd.National authorisation (PA)Marketed
Methofill 30 mg solution for injection in pre-filled injectorAccord Healthcare Ireland Ltd.National authorisation (PA)Marketed
Methofill 7.5 mg solution for injection in pre-filled injectorAccord Healthcare Ireland Ltd.National authorisation (PA)Marketed
Methotrexate 1 g/10 ml InjectionPfizer Healthcare Ireland Unlimited CompanyNational authorisation (PA)Marketed
Methotrexate 2.5 mg TabletsAbcur ABNational authorisation (PA)Marketed
Methotrexate 2.5 mg tabletsAccord Healthcare Ireland Ltd.National authorisation (PA)Marketed

All 48 products with Methotrexate →

Other substances in ATC group L01BA

The ATC system groups medicines by the part of the body they act on and their chemistry. On the HPRA list, 5 other active substances share the group L01BA with this product:

Pemetrexed (8) · Pemetrexed disodium (3) · Pemetrexed ditromethamine (3) · Pemetrexed diacid (1) · Pemetrexed Disodium 2.5 hydrate (1)

Numbers in brackets are products on the HPRA list. Sharing an ATC group does not mean two medicines can replace each other.

The licence holder

medac Gesellschaft für klinische Spezialpräparate mbH holds 28 products on the HPRA list, with 13 different active substances; 10 of the products are marked as marketed.

Shortages and approvals, every Friday

One email a week with ongoing EU and US medicine shortages, new EMA and FDA approvals and clinical trials recruiting in Ireland.

Free. Unsubscribe from any email with one click. See our privacy policy.

This listing is regulatory information, not medical advice — consult the package leaflet, SPC, or a healthcare professional. For the authoritative record see the HPRA register.

How this page is built

The facts on this page are pulled directly from the HPRA's (Health Products Regulatory Authority) official open dataset — they are not written from memory, and nothing here is summarised or edited. Each field below names the dataset it came from, so you can check it yourself.

This page is built automatically: a daily sync job downloads HPRA's published XML export and copies the licence number, holder, active substance(s), dosage form, route, ATC code(s), authorisation date and prescription status directly into this page — no AI drafting and no per-product editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The HPRA data on this page was last retrieved on 22 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.